Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-12
DOI
10.1007/s00415-020-09757-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease
- (2018) Jonathan Schulz et al. BRAIN
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies
- (2018) Matthew D. F. McInnes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment
- (2018) Jennifer G. Goldman et al. MOVEMENT DISORDERS
- Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease
- (2018) Joseph R. Winer et al. JAMA Neurology
- Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
- (2017) Ganqiang Liu et al. LANCET NEUROLOGY
- Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
- (2017) Anette Schrag et al. LANCET NEUROLOGY
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- Non-motor features of Parkinson disease
- (2017) Anthony H.V. Schapira et al. NATURE REVIEWS NEUROSCIENCE
- Biomarkers of cognitive decline in Parkinson's disease
- (2015) Chin-Hsien Lin et al. PARKINSONISM & RELATED DISORDERS
- What can biomarkers tell us about cognition in Parkinson's disease?
- (2014) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Risk factors for hallucinations in Parkinson's disease: Results from a large prospective cohort study
- (2013) Kangdi Zhu et al. MOVEMENT DISORDERS
- Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?
- (2013) Gordon W. Duncan et al. MOVEMENT DISORDERS
- Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
- (2012) Per Svenningsson et al. LANCET NEUROLOGY
- Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease
- (2011) D. Weintraub et al. BRAIN
- The economic impact of cognitive impairment in Parkinson's disease
- (2011) Corinna Vossius et al. MOVEMENT DISORDERS
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease
- (2009) C. H. Williams-Gray et al. JOURNAL OF NEUROLOGY
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started